See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days

News Digest / StockInvest.us

Author: StockInvest.us

09:07am, Wednesday, Aug 06, 2025

Verona Pharma Sees Strong Sales and FDA Approval Amid $10B Merck Acquisition Plans and Financial Challenges

Verona Pharma plc (NASDAQ: VRNA) - Company Overview Verona Pharma is a biopharmaceutical company focused on developing innovative therapies for respiratory diseases with significant unmet medical needs. The company has gained attention recently due to the FDA approval of its first commercial prod...

09:06am, Wednesday, Aug 06, 2025

Paysign Reports Q2 2025: Strong Revenue and Net Income Growth Despite Plasma Revenue Challenges

09:06am, Wednesday, Aug 06, 2025

Conduent Faces Challenges in Q2 2025 with Revenue Dip and Significant Net Loss Amid Strategy Shift

09:06am, Wednesday, Aug 06, 2025

International Seaways Reports Q2 2025: Revenue Decline Amid Strategic Investments and Strong Liquidity

09:05am, Wednesday, Aug 06, 2025

SmartRent Q2 2025: Revenue Falls 21%, Net Loss Widens Amid Struggles and Growth in Hosted Services

09:05am, Wednesday, Aug 06, 2025

Solo Brands Faces Challenges Amid Restructuring Efforts and Declining Sales in Q2 2025

09:04am, Wednesday, Aug 06, 2025

Centuri Holdings Reports Mixed Q2 2025 Results with Revenue Growth Amid Rising Costs

C

09:04am, Wednesday, Aug 06, 2025

Solitario Resources Reports Q2 2025 Loss Amid Increased Exploration Expenses and Improved Cash Position

09:03am, Wednesday, Aug 06, 2025

Southwest Gas Holdings Reports Q2 2025: Mixed Financial Results Amid Revenue Decline

S

09:03am, Wednesday, Aug 06, 2025

Pulmatrix Reports Improved Losses Amid Revenue Decline and Merger Uncertainties

09:02am, Wednesday, Aug 06, 2025

Pinnacle West Reports Mixed Q2 2025 Results: Revenue Up, Net Income and Profitability Down

09:01am, Wednesday, Aug 06, 2025

Marriott Vacations Reports Mixed Q2 2025 Performance Amid Revenue Growth and Rising Expenses

09:01am, Wednesday, Aug 06, 2025

Organon Reports Mixed Q2 Results Amid Revenue Decline and Strategic Growth Opportunities

08:16am, Wednesday, Aug 06, 2025

Shopify Reports 31% Revenue Growth in Q2 2025 Amid Rising Costs and Investment Volatility

08:15am, Wednesday, Aug 06, 2025

iTeos Therapeutics to Wind Down Operations Following GSK Collaboration Termination and Heavy Losses

«
1
2
...
84
85
86
87
88
89
90
...
296
297
»